Cargando…
Second Re-irradiation of Brain Metastases: A Review of Studies Involving Stereotactic Radiosurgery
Due to advances in the systemic and local treatment, e.g., targeted therapy, immune checkpoint inhibitors, and stereotactic radiotherapy, an increasing proportion of patients with brain metastases now survive for several years. However, long-term survival is not synonymous to permanent local control...
Autores principales: | Nieder, Carsten, Yobuta, Rosalba, Mannsåker, Bård |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373883/ https://www.ncbi.nlm.nih.gov/pubmed/30788201 http://dx.doi.org/10.7759/cureus.3712 |
Ejemplares similares
-
Second Re-irradiation: Clinical Examples of Worthwhile Treatment
por: Nieder, Carsten, et al.
Publicado: (2018) -
LabBM Score and Extracranial Score As New Tools for Predicting Survival in Patients with Brain Metastases Treated with Focal Radiotherapy
por: Nieder, Carsten, et al.
Publicado: (2020) -
Late Brain Oligometastases Diagnosed at Least 36 Months after Cancer Detection are Associated with Favorable Survival Outcome
por: Nieder, Carsten, et al.
Publicado: (2020) -
Presence of Brain Metastases at Initial Diagnosis of Cancer: Patient Characteristics and Outcome
por: Nieder, Carsten, et al.
Publicado: (2019) -
Dual Use of the METSSS Model Predicting Survival After Palliative Radiotherapy: An Exploratory Analysis
por: Nieder, Carsten, et al.
Publicado: (2022)